Home > Financial Ratios > LYKA LABS

LYKA LABS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 14.1318.0952.1222.82-5.97

What is the latest Core EBITDA Margin ratio of LYKA LABS ?

The latest Core EBITDA Margin ratio of LYKA LABS is 14.13 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202414.13
Mar202318.09
Mar202252.12
Mar202122.82
Mar2020-5.97

How is Core EBITDA Margin of LYKA LABS Trending?

Years Core EBITDA Margin % Change
Mar2024 14.13
-21.89
Mar2023 18.09
-65.29
Mar2022 52.12
128.40
Mar2021 22.82
Positive
Mar2020 -5.97 -

Other Financial Ratios of LYKA LABS


Compare Core EBITDA Margin ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹412.9 Cr -0.4% 3.7% 10.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,176.0 Cr -0.3% -2.9% 11.5% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 0.7% 7.4% 48.1% Stock Analytics
CIPLA ₹121,592.0 Cr -0.1% 0.2% -2.1% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 10.3% 11.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,024.0 Cr 2.3% -0.5% 13.8% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-0.4%

3.7%

10.6%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses